查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
癌症切片檢查市場:各產品，各切片檢查類型 - 市場規模，佔有率，展望，機會分析，2023年～2030年
市場調查報告書
商品編碼
1330119

癌症切片檢查市場:各產品，各切片檢查類型 - 市場規模，佔有率，展望，機會分析，2023年～2030年

Cancer Biopsy Market, By Product, Biopsy Type (((Tissue Biopsy (Needle Biopsy, Liquid Biopsy, and Others))), and By Application By Geography )- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

活檢是一種醫學測試，從體內採集組織或細胞樣本並在實驗室進行測試。另一方面，癌症活檢涉及從受影響的患者身上取出組織或細胞，以發現癌症的存在、原因和程度。因此，隨著全世界癌症負擔的增加，癌症切片的使用也快速增加。

市場動態：

腫瘤疾病盛行率不斷上升，老年人口不斷增加，液體活檢的出現和採用越來越多，公眾對基因檢測和遺傳性腫瘤疾病的認識不斷提高，活檢技術不斷改進。發展是預計促進腫瘤疾病成長的關鍵因素全球癌症切片市場。

本調查的主要特徵

  • 本報告提供以2022年為基準年的預測期間（2023-2030 年）之全球癌症切片檢查市場的市場規模和復合年增長率（CAGR %）相關的詳區隔析。
  • 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球癌症切片檢查市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球癌症切片檢查市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球癌症切片檢查市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市場動態，法規，趨勢分析

  • 市場動態
    • 癌症病患的負擔增加
    • 技術性及臨床性課題
    • 液態生物檢體引進的增加
  • 影響分析
  • 主要的焦點
  • 法規情勢
  • 產品上市/核准
  • PEST分析
  • 波特分析
  • 合併·收購情勢

第4章 癌症切片檢查的全球市場-冠狀病毒(COVID-19)流行的影響

  • COVID-19流行病學
  • 供給面和需求面的分析
  • 經濟影響

第5章 癌症切片檢查的全球市場:各產品，2023-2030年

  • 設備
  • 套件·消耗品
  • 服務

第6章 癌症切片檢查的全球市場:各切片檢查類型，2023-2030年

  • 組織切片檢查
  • 針切片檢查
  • 液態生物檢體
  • 其他

第7章 癌症切片檢查的全球市場:各用途，2023-2030年

  • 乳癌
  • 大腸癌症
  • 子宮頸癌症
  • 肺癌症
  • 前列腺癌症
  • 皮膚癌症
  • 血液癌症
  • 腎臟癌症
  • 肝臟癌症
  • 胰臟癌症
  • 卵巢癌症
  • 其他

第8章 癌症切片檢查的全球市場:各地區，2023-2030年

  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東

第9章 競爭情形

  • QIAGEN
  • Illumina, Inc.
  • Angle PLC
  • Myriad Genetics
  • COUNSYL, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • BD(Becton, Dickinson and Company)
  • Helio Health(Laboratory for Advanced Medicine)

第10章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5930

A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.

Market Dynamics:

Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.

For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.

Key features of the study:

  • This report provides in-depth analysis of the global cancer biopsy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.

Detailed Segmentation:

  • Global Cancer Biopsy Market , By Product:
    • Instruments
    • Kits and Consumables
    • Services
  • Global Cancer Biopsy Market , By Biopsy Type:
    • Tissue Biopsy
      • Needle Biopsy
    • Fine Needle Aspiration (FNA)
    • Core Needle Biopsy (CNB)
    • Liquid Biopsy
    • Others
  • Global Cancer Biopsy Market, By Application:
    • Breast Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Blood Cancer
    • Kidney Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Ovarian Cancer
    • Others
  • Global Cancer Biopsy Market , By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • QIAGEN
    • Illumina, Inc.
    • Angle PLC
    • Myriad Genetics
    • COUNSYL, Inc.
    • Hologic, Inc.
    • Biocept, Inc.
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • F.Hoffmann-La Roche Ltd.
    • Epigenomics AG
    • BD (Becton, Dickinson and Company)
    • Helio Health (Laboratory for Advanced Medicine)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Biopsy Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising burden of oncology disorders
    • Technical and clinical challenges
    • Increasing adoption of liquid biopsies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cancer Biopsy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cancer Biopsy Market, By Product, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Kits and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Cancer Biopsy Market, By Biopsy Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Tissue Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Needle Biopsy
    • Fine Needle Aspiration (FNA)
    • Core Needle Biopsy (CNB)
  • Liquid Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cancer Biopsy Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Colorectal Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Blood Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Kidney Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Pancreatic Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Ovarian Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Cancer Biopsy Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)

9. Competitive Landscape

  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
  • Angle PLC
  • Myriad Genetics
  • COUNSYL, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • BD (Becton, Dickinson and Company)
  • Helio Health (Laboratory for Advanced Medicine)
  • Analyst Views

10. Section

  • Research Methodology
  • About us